Department of Otolaryngology Head and Neck Surgery Division of Research
Active studies that are open to enrollment:
Principle Investigator |
Study |
| C. Baldassari, MD |
Quality of Life scores following Adenotonsillectomy for Mild Obstructive Sleep Apnea in Children:a Randomized Prospective Trial |
| C. Derkay, MD | Hemostatic Control after Adenotonsillectomy - Open Label QuikClot Study |
| C. Baldassari, MD | Turbinate Cauterization in Pediatric Patients with Nasal Obstruction A Randomized Prospective Trial |
| C. Baldassari, MD, D. Darrow, MD, C. Derkay, MD |
The Laryngeal Mask Airway in Pediatric Adenotonsillectomy |
| C. Baldassari, MD | Turbinate Cauterization in Pediatric Patients with Nasal Obstruction A Randomized Prospective Trial |
|
S. Moody Antonio, MD, |
Cochlear Implant Database |
| C. Derkay, MD, D. Darrow, MD. |
OK-432 (Picibanil) Sclerotherapy- A Multi-Center Trial (Treatment of Life-Threatening Lymphangiomas) |
| C. Derkay, MD, D. Darrow, MD, J. Sinacori, MD |
Genetic Susceptibility in Recurrent Respiratory Papillomatosis - RC3145 |
| C. Derkay, MD, D. Darrow, MD, C. Baldassari, MD |
A Multicenter, Randomized, Double-Blind Clinical Trial to Assess the Efficacy and Safety of Ciprofloxacin 0.3% plus Fluocinolone Acetonide 0.025% Otic Solution Compared to Ciprofloxacin 0.3% Otic Solution and to Fluocinolone Acetondie 0.025% Otic Solution in the Treatment of Acute Otitis Media with Tympanostomy Tubes in Pediatric Patients. |
Sub Investigators |
Study |
| D. Karakla, MD, M. Bak, MD |
RTOG 0920: A Phase III Study of Postoperative Radiation Therapy (IMRT) +/- Cetuximab for Locally-Advanced Resected Head and Neck Cancer |
| D. Karakla, MD, M. Bak, MD |
RTOG 1008: A Randomized Phase II Study of Adjuvant Concurrent Radiation and Chemotherapy Versus Radiation Alone in Resected High-Risk Malignant Salivary Gland Tumors |
| D. Karakla, MD, M. Bak, MD |
RTOG 1008: A Randomized Phase II Study of Adjuvant Concurrent Radiation and Chemotherapy Versus Radiation Alone in Resected High-Risk Malignant Salivary Gland Tumors |
| D. Karakla, MD, M. Bak, MD |
RTOG 1016: Phase III Trial of Radiotherapy Plus Cetuximab Versus Chemoradiotherapy in HPV-Associated Oropharynx Cancer |